Tools for diagnosis of leukodystrophies and other disorders presenting with white matter disease

Current Neurology and Neuroscience Reports

Volumn 5, Issue 2, 2005, Pages 110-118

  Vanderver, Adeline ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; DISORDERS OF CARBOHYDRATE METABOLISM; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DISORDERS OF METAL METABOLISM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DISORDERS OF PEROXISOMAL FUNCTIONS; ENDOCRINE DISEASE; GENETIC DISORDER; HUMAN; INBORN ERROR OF METABOLISM; LEUKODYSTROPHY; LYSOSOME STORAGE DISEASE; MOLECULAR GENETICS; MUSCULAR DYSTROPHY; NEUROIMAGING; PATIENT MONITORING; PROGNOSIS; REVIEW; VITAMIN DEFICIENCY; WHITE MATTER;

EID: 16844377956     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-005-0008-1     Document Type: Review

References (59)

1. Pozo-Rosich P, Villoslada P, Canton A, et al.: Reversible white matter alterations in encephalopathy associated with autoimmune thyroid disease. J Neurol 2002, 249:1063-1065.
2. Prayer D, Grois N, Prosch H, et al.: MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis. Am J Neuroradiol 2004, 25:880-891.
3. Longhi R, Valsasina R, Butte C, et al.: Cranial computerized tomography in dihydropteridine reductase deficiency. J Inherit Metab Dis 1985, 8:109-112.
4. Kendall BE, Kingsley DP, Leonard JV, et al.: Neurological features and computed tomography of the brain in children with ornithine carbamoyl transferase deficiency. J Neurol Neurosurg Psychiatry 1983, 46:28-34.
5. Takayanagi M, Ohtake A, Ogura N, et al.: A female case of ornithine transcarbamylase deficiency with marked computed tomographic abnormalities of the brain. Brain Dev 1984, 6: 8-60.
6. Christodoulou J, Qureshi A, McInnes RR, Clarke JT: Ornithine transcarbamylase deficiency presenting with strokelike episodes. J Pediatr 1993, 122:423-425.
7. Kurihara K, Takanashi J, Tomita M, et al.: Magnetic resonance imagine in late onset ornithine transcarbamylase deficiency. Brain Dev 2003, 25:40-44.
8. Jan W, Zimmerman RA, Wang ZJ, et al.: MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiology 2003, 45:393-399.
9. Sener RN: Diffusion magnetic resonance imaging in intermediate form of maple syrup urine disease. J Neuroimaging 2002, 12:368-370.
10. Schonberger S, Schweiger B, Schwahn B, et al.: Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab 2004, 82:69-75.
11. Press GA, Barshop BA, Haas RH, et al.: Abnormalities of the brain in nonketotic hyperglycinemia: MR manifestations. Am J Neuroradiol 1989, 10:315-321.
12. Twomey EL, Naughten ER, Donoghue VB, Ryan S: Neuroimaging findings in glutaric aciduria type 1. Pediatr Radiol 2003, 33:823-830.
13. Uziel G, Garavaglia B, Ciceri E, et al.: Riboflavin-responsive glutaric aciduria type II presenting as a leukodystrophy. Pediatr Neurol 1995, 13:333-335.
14. van Domburg PH, Willemsen MA, Rotteveel JJ, et al.: Sjogren-Larsson syndrome: clinical and MRI/MRS findings in FALDH-deficient patients. Neurology 1999, 52:1345-1352.
15. Feliz B, Witt DR, Harris BT: Propionic academia: a neuropathology case report and review of prior cases. Arch Pathol Lab Med 2003, 127:e325-e328.
16. Darin N, Oldfors A, Moslemi AR, et al.: The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities. Ann Neurol 2001, 49:377-383.
17. Barkhof F, Verrips A, Wesseling P, et al.: Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology 2000, 7: 69-876.
18. Poll-The BT, Gootjes J, Duran M, et al.: Peroxisome biogenesis disorders with prolonged survival: phenotypic expression in a cohort of 31 patients. Am J Med Genet 2004, 126A:333-338.
19. Barth PG, Gootjes J, Bode H, et al.: Late onset white matter disease in peroxisome biogenesis disorder. Neurology 2001, 57:1949-1955.
20. Sylvain M, Arnold DL, Scriver CR, et al.: Magnetic resonance spectroscopy in Niemann-Pick disease type C: correlation with diagnosis and clinical response to cholestyramine and lovastatin. Pediatr Neurol 1994, 10:228-232.
21. Grau AJ, Brandt T, Weisbrod M, et al.: Adult Niemann-Pick disease type C mimicking features of multiple sclerosis. J Neurol Neurosurg Psychiatry 1997, 63:552.
22. Chen CY, Zimmerman RA, Lee CC, et al.: Neuroimaging findings in late infantile GM1 gangliosidosis. Am J Neuroradiol 1998, 19:1628-1630.
23. Campdelacreu J, Munoz E, Gomez B, et al.: Generalised dystonia with an abnormal magnetic resonance imaging signal in the basal ganglia: a case of adult-onset GM1 gangliosidosis. Mov Disord 2002, 17:1095-1097.
24. Mugikura S, Takahashi S, Higano S, et al.: MR findings in Tay-Sachs disease. J Comput Assist Tomogr 1996, 20:551-555.
25. Nassogne MC, Commare MC, Lellouch-Tubiana A, et al.: Unusual presentation of GM2 gangliosidosis mimicking a brain stem tumor in a 3-year-old girl. Am J Neuroradiol 2003, 24:840-842.
26. Barone R, Parano E, Trifiletti RR, et al.: White matter changes mimicking a leukodystrophy in a patient with mucopolysaccharidosis: characterization by MRI. J Neurol Sci 2002, 195:171-175.
27. Matheus MG, Castillo M, Smith JK, et al.: Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology 2004, 46:666-672.
28. Cheon JE, Kim IO, Hwang YS, et al.: Leukodystrophy in children: a pictoral review of MR Imaging Features. Radiographics 2002, 22:461-476.
29. Mackay MT, Kornberg AJ, Shield L, et al.: Congenital muscular dystrophy, white-matter abnormalities, and neuronal migration disorders: the expanding concept. J Child Neurol 1998, 13: 81-487.
30. Sugita K, Takanashi J, Ishii M, Niimi H: Comparison of MRI white matter changes with neuropsychologic impairment in Cockayne syndrome. Pediatr Neurol 1992, 8:295-298.
31. Thompson JE, Smith M, Castillo M, et al.: MR in children with L-carnitine deficiency. Am J Neuroradiol 1996, 17:1585-1588.
32. Huck JH, Verhoeven NM, Struys EA, et al.: Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy. Am J Hum Genet 2004, 74:745-751.
33. Kim TS, Kim IO, Kim WS, et al.: MR of childhood metachromatic leukodystrophy. Am J Neuroradiol 1997, 18: 33-738.
34. Faerber EN, Melvin J, Smergel EM: MRI appearances of metachromatic leukodystrophy. Pediatr Radiol 1999, 29: 69-672.
35. Jones BV, Barron TF, Towfighi J: Optic nerve enlargement in Krabbe's disease. Am J Neuroradiol 1999, 20:1228-1231.
36. Vasconcellos E, Smith M: MRI nerve root enhancement in Krabbe disease. Pediatr Neurol 1998, 19:151-152.
37. Given CA, Santos CC, Durden DD: Intracranial and spinal MR imaging findings associated with Krabbe's disease: case report. Am J Neuroradiol 2001, 22:1782-1785.
38. Loes DJ, Hite S, Moser H, et al.: Adrenoleukodystrophy: a scoring method for brain MR observations. Am J Neuroradiol 1994, 15:1761-1766.
39. Toft PB, Geiss-Holtorff R, Rolland MO, et al.: Magnetic resonance imaging in juvenile Canavan disease. Eur J Pediatr 1993, 152:750-753.
40. van der Knaap MS, Naidu S, Breiter SN, et al.: Alexander disease: diagnosis with MR imaging. Am J Neuroradiol 2001, 22:541-552.
41. Hanefeld F, Holzbach U, Kruse B, et al.: Diffuse white matter disease in three children: an encephalopathy with unique features on magnetic resonance imaging and proton magnetic resonance spectroscopy. Neuropediatrics 1993, 24:244-248.
42. Schiffmann R, Moller JR, Trapp BD, et al.: Childhood ataxia with diffuse central nervous system hypomyelination. Ann Neurol 1994, 35:331-340.
43. van der Knaap MS, Barth PG, Gabreels FJ, et al.: A new leukoencephalopathy with vanishing white matter. Neurology 1997, 48:845-855.
44. van der Knaap MS, Wevers RA, Kure S, et al.: Increased cerebrospinal fluid glycine: a biochemical marker for a leukoencephalopathy with vanishing white matter. Ann Neurol 1999, 14:728-731.
45. van der Knaap MS, Leegwater PA, Konst AA, et al.: Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol 2002, 51:264-270.
46. Hobson GM, Davis AP, Stowell NC, et al.: Mutations in noncoding regions of the proteolipid protein gene in Pelizaeus-Merzbacher disease. Neurology 2000, 55: 089-1096.
47. Uhlenberg B, Schuelke M, Ruschendorf F, et al.: Mutations in the gene encoding gap junction protein alpha 12 (Connexin 46.6) cause pelizaeus-merzbacher-like disease. Am J Hum Genet 2004, 75:251-260.
48. Plecko B, Stockler-Ipsiroglu S, Gruber S, et al.: Degree of hypomyelination and magnetic resonance spectroscopy findings in patients with Pelizaeus Merzbacher phenotype. Neuropediatrics 2003, 34:127-136.
49. van der Knaap MS, Barth PG, Stroink H, et al.: Leukoencephalopathy with swelling and a discrepantly mild clinical course in eight children. Ann Neurol 1995, 37:324-334.
50. Leegwater PA, Yuan BQ, van der Steen J, et al.: Mutations of MLC1 (KIAA0027), encoding a putative membrane protein, cause megalencephalic leukoencephalopathy with subcortical cysts. Am J Hum Genet 2001, 68:831-838.
51. Tolmie JL, Shillito P, Hughes-Benzie R, Stephenson JB: The Aicardi-Goutieres syndrome (familial, early onset encephalopathy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis). J Med Genet 1995, 32:881-884.
52. Lebon P, Badoual J, Ponsot G, et al.: Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy. J Neurol Sci 1988, 84:201-208.
53. Crow YJ, Jackson AP, Roberts E, et al.: Aicardi-Goutieres syndrome displays genetic heterogeneity with one locus (AGS1) on chromosome 3p21. Am J Hum Genet 2000, 67: 13-221.
54. Blau N, Bonafe L, Krageloh-Mann I, et al.: Cerebrospinal fluid pterins and folates in Aicardi-Goutieres syndrome: a new phenotype. Neurology 2003, 61:642-647.
55. Polizzi A, Pavone P, Parano E, et al.: Lack of progression of brain atrophy in Aicardi-Goutieres syndrome. Pediatr Neurol 2001, 24:300-302.
56. van der Knaap MS, Naidu S, Pouwels PJ, et al.: New syndrome characterized by hypomyelination with atrophy of the basal ganglia and cerebellum. Am J Neuroradiol 2002, 23: 466-1474.
57. van der Knaap MS, van der Voom P, Barkof F, et al.: A new leukoencephalopathy with brainstem and spinal cord involvement and high lactate. Ann Neurol 2003, 53:252-258.
58. Linnankiviv T, Lundbom N, Autti T, et al.: Five new cases of a recently described leukoencephalopathy with brain lactate. Neurology 2004, 63:688-692.
59. Serko SV, Pronin IN, Bykova OV, et al.: Five patients with a recently described novel leukoencephalopathy with brainstem and spinal cord involvement and elevated lactate. Neuropediatrics 2004, 35:1-5.